Dana-Farber Cancer Institute /ID# 48324

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma

Studies at this site

• A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma — Completed